MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0132786

Медицинская библиотека · PloS one · 2015

TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.

Greco Stephanie H, Tomkötter Lena, Vahle Anne-Kristin, Rokosh Rae, Avanzi Antonina, Mahmood Syed Kashif, Deutsch Michael, Alothman Sara, Alqunaibit Dalia, Ochi Atsuo, Zambirinis Constantinos, Mohaimin Tasnima, Rendon Mauricio, Levie Elliot, Pansari Mridul, Torres-Hernandez Alejandro, Daley Donnele, Barilla Rocky, Pachter H Leon, Tippens Daniel, Malik Hassan, Boutajangout Allal, Wisniewski Thomas, Miller George

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАВалидационное исследованиеПеревод в очереди

Аннотация

Cancer cachexia is a debilitating condition characterized by a combination of anorexia, muscle wasting, weight loss, and malnutrition. This condition affects an overwhelming majority of patients with pancreatic cancer and is a primary cause of cancer-related death. However, few, if any, effective therapies exist for both treatment and prevention of this syndrome. In order to develop novel therapeutic strategies for pancreatic cancer cachexia, appropriate animal models are necessary. In this study, we developed and validated a syngeneic, metastatic, murine model of pancreatic cancer cachexia. Using our model, we investigated the ability of transforming growth factor beta (TGF-β) blockade to mitigate the metabolic changes associated with cachexia. We found that TGF-β inhibition using the anti-TGF-β antibody 1D11.16.8 significantly improved overall mortality, weight loss, fat mass, lean body mass, bone mineral density, and skeletal muscle proteolysis in mice harboring advanced pancreatic cancer. Other immunotherapeutic strategies we employed were not effective. Collectively, we validated a simplified but useful model of pancreatic cancer cachexia to investigate immunologic treatment strategies. In addition, we showed that TGF-β inhibition can decrease the metabolic changes associated with cancer cachexia and improve overall survival.

Для цитирования: Greco Stephanie H, Tomkötter Lena, Vahle Anne-Kristin, Rokosh Rae, Avanzi Antonina, Mahmood Syed Kashif, Deutsch Michael, Alothman Sara, Alqunaibit Dalia, Ochi Atsuo, Zambirinis Constantinos, Mohaimin Tasnima, Rendon Mauricio, Levie Elliot, Pansari Mridul, Torres-Hernandez Alejandro, Daley Donnele, Barilla Rocky, Pachter H Leon, Tippens Daniel, Malik Hassan, Boutajangout Allal, Wisniewski Thomas, Miller George. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.. PloS one. 2015. DOI: 10.1371/journal.pone.0132786.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.